REFERENCES
- Bennett, I. F.: The tranquilizers. J. Am. Pharm. A. 18:474 (August) 1957.
- Fabing, H. D.: The ataractic drugs: Their uses and limitations in psychiatry. Am. Prof. Pharm. 22:413, 1956.
- Hartley, Frank: Tranquillising the tranquillisers. Pharm. J. 177:245 (September) 1956.
- Berger, F. M.: The chemistry and mode of action of the tranquilizing drugs. Ann. New York Acad. Sc. 67:685 (May) 1957.
- Goldstein, S. W.: Ataraxics, sedatives, tranquilizers. J. Am. Pharm. A. 18:92 (February) 1957.
- Gerard, R. W.: Concluding remarks (meprobamate symposium). Ann. New York Acad. Sc. 67:885 (May) 1957.
- Alexander, L.: Differential effects of the new “psychotropic” drugs. Ibid., p. 758.
- Truitt, E. B.: Pharmacology of the ataractic drugs. Mod. Med. 25:77 (January) 1957.
- Barsa, J. A.: The dual action of the tranquilizers. AM. J. Psychiat. 114:74 (July) 1957.
- Hollister, L.: Complications from the use of tranquilizing drugs. New England J. Med. 257:170 (July) 1957.
- Schiele, B. C., Anderson, R. W. and Simon, W.: Current status of chlorpromazine and reserpine in psychiatric practice. Journal-Lancet 76:179 (July) 1956.